BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11014658)

  • 1. The usefulness of a panel of immunostains in the diagnosis and differentiation of metastatic malignancies in pericardial effusions.
    Gupta RK; Kenwright DN; Fauck R; Lallu S; Naran S
    Cytopathology; 2000 Oct; 11(5):312-21. PubMed ID: 11014658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of malignant pericarditis: a single centre experience.
    Pawlak Cieślik A; Szturmowicz M; Fijałkowska A; Gątarek J; Gralec R; Błasińska-Przerwa K; Szczepulska-Wójcik E; Skoczylas A; Bilska A; Tomkowski W
    Kardiol Pol; 2012; 70(11):1147-53. PubMed ID: 23180523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cytology to evaluate pericardial effusions.
    King DT; Nieberg RK
    Ann Clin Lab Sci; 1979; 9(1):18-23. PubMed ID: 420509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2, a unique marker of malignancy in effusion cytology.
    Jiang H; Gupta R; Somma J
    Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of extramammary malignancy metastatic to the breast by fine needle biopsy.
    Wood B; Sterrett G; Frost F; Swarbrick N
    Pathology; 2008 Jun; 40(4):345-51. PubMed ID: 18446623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
    Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
    Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pericardial metastasis of lung cancer--report of 13 cases].
    Zuo ZL
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):142-4. PubMed ID: 2806044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic squamous-cell carcinoma in pericardial effusion: report of four cases, two with cardiac tamponade.
    Hoda RS; Cangiarella J; Koss LG
    Diagn Cytopathol; 1998 Jun; 18(6):422-4. PubMed ID: 9626514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous metastasis of lung carcinoma: a retrospective study of 12 cases.
    Dhambri S; Zendah I; Ayadi-Kaddour A; Adouni O; El Mezni F
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):722-6. PubMed ID: 20735519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericardial and Pleural Metastases: Clinical, Histologic, and Molecular Differences.
    Karpathiou G; Mobarki M; Stachowicz ML; Hathroubi S; Patoir A; Tiffet O; Froudarakis M; Peoc'h M
    Ann Thorac Surg; 2018 Sep; 106(3):872-879. PubMed ID: 29852147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathologic analysis of pericardial effusions in 116 cases: Implications for poor prognosis in lung cancer patients with positive interpretations.
    He B; Yang Z; Zhao P; Li YJ; Wang JG
    Diagn Cytopathol; 2017 Apr; 45(4):287-293. PubMed ID: 28139896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period.
    Dragoescu EA; Liu L
    Cancer Cytopathol; 2013 May; 121(5):242-51. PubMed ID: 23362233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
    Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
    Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single primary lung cancer consisting of three cancer cell types (small cell carcinoma, adenocarcinoma, and squamous cell carcinoma) in which each had metastasized to different lymph nodes.
    Shikata H; Ueda Y; Tsuchishima S; Nonaka T; Watanabe Y; Matsubara J
    Jpn J Thorac Cardiovasc Surg; 2002 May; 50(5):216-9. PubMed ID: 12048916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.